Literature DB >> 22024133

Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis by phosphorylation of Mcl-1, promoting its degradation and freeing Bak from sequestration.

Rong Chu1, David T Terrano, Timothy C Chambers.   

Abstract

Mcl-1 is one of the major anti-apoptotic members of the Bcl-2 family of apoptotic regulatory proteins. In this study we investigated the role of Mcl-1 in mitotic arrest-induced apoptosis. Vinblastine treatment of KB-3 cells initially resulted in a phosphatase-sensitive mobility shift in Mcl-1 and then subsequent loss of Mcl-1 protein expression which was prevented by MG132, suggesting that phosphorylation triggered proteosome-mediated degradation. Mcl-1 phosphorylation/degradation was a specific response to microtubule inhibition and did not occur in response to lethal concentrations of DNA damaging agents. Vinblastine treatment caused degradation of Mcl-1 in cells in which apoptosis was blocked by Bcl-xL overexpression, indicating that Mcl-1 degradation was not a consequence of apoptosis. A partial reversible phosphorylation of Mcl-1 was observed in synchronized cells traversing mitosis, whereas more extensive phosphorylation and subsequent degradation of Mcl-1 was observed if synchronized cells were treated with vinblastine. Mcl-1 phosphorylation closely paralleled cyclin B expression, and specific cyclin-dependent kinase (Cdk) inhibitors blocked vinblastine-induced Mcl-1 phosphorylation, its subsequent degradation, and improved cell viability after mitotic arrest. Co-immunoprecipitation studies indicated that Mcl-1 was complexed with Bak, but not Bax or Noxa, in untreated cells, and that Bak became activated in concert with loss of Mcl-1 expression. These results suggest that Cdk1/cyclin B plays a key role in mitotic arrest-induced apoptosis via Mcl-1 phosphorylation, promoting its degradation and subsequently releasing Bak from sequestration.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024133      PMCID: PMC3242896          DOI: 10.1016/j.bcp.2011.10.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  23 in total

Review 1.  Unknotting the roles of Bcl-2 and Bcl-xL in cell death.

Authors:  Ryungsa Kim
Journal:  Biochem Biophys Res Commun       Date:  2005-07-29       Impact factor: 3.575

2.  Unraveling MCL-1 degradation.

Authors:  J T Opferman
Journal:  Cell Death Differ       Date:  2006-05-19       Impact factor: 15.828

3.  Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.

Authors:  Ulrich Maurer; Céline Charvet; Allan S Wagman; Emmanuel Dejardin; Douglas R Green
Journal:  Mol Cell       Date:  2006-03-17       Impact factor: 17.970

4.  Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1.

Authors:  Lyubomir T Vassilev; Christian Tovar; Shaoqing Chen; Dejan Knezevic; Xiaolan Zhao; Hongmao Sun; David C Heimbrook; Li Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

5.  Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.

Authors:  M Fan; L Du; A A Stone; K M Gilbert; T C Chambers
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

6.  Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

Authors:  Ingrid E Wertz; Saritha Kusam; Cynthia Lam; Toru Okamoto; Wendy Sandoval; Daniel J Anderson; Elizabeth Helgason; James A Ernst; Mike Eby; Jinfeng Liu; Lisa D Belmont; Josh S Kaminker; Karen M O'Rourke; Kanan Pujara; Pawan Bir Kohli; Adam R Johnson; Mark L Chiu; Jennie R Lill; Peter K Jackson; Wayne J Fairbrother; Somasekar Seshagiri; Mary J C Ludlam; Kevin G Leong; Erin C Dueber; Heather Maecker; David C S Huang; Vishva M Dixit
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

7.  Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members.

Authors:  Meenakshi Upreti; Christopher S Lyle; Brian Skaug; Lihua Du; Timothy C Chambers
Journal:  J Biol Chem       Date:  2006-03-30       Impact factor: 5.157

8.  Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis.

Authors:  John G Clohessy; Jianguo Zhuang; Jasper de Boer; Gabriel Gil-Gómez; Hugh J M Brady
Journal:  J Biol Chem       Date:  2005-12-27       Impact factor: 5.157

9.  MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol.

Authors:  Aaron M Domina; Julie A Vrana; Mark A Gregory; Stephen R Hann; Ruth W Craig
Journal:  Oncogene       Date:  2004-07-08       Impact factor: 9.867

10.  The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide.

Authors:  Cheryl Brantley-Finley; Christopher S Lyle; Lihua Du; Mary E Goodwin; Toria Hall; Dominika Szwedo; G P Kaushal; Timothy C Chambers
Journal:  Biochem Pharmacol       Date:  2003-08-01       Impact factor: 5.858

View more
  27 in total

1.  The apoptotic mechanism of action of the sphingosine kinase 1 selective inhibitor SKI-178 in human acute myeloid leukemia cell lines.

Authors:  Taryn E Dick; Jeremy A Hengst; Todd E Fox; Ashley L Colledge; Vijay P Kale; Shen-Shu Sung; Arun Sharma; Shantu Amin; Thomas P Loughran; Mark Kester; Hong-Gang Wang; Jong K Yun
Journal:  J Pharmacol Exp Ther       Date:  2015-01-06       Impact factor: 4.030

2.  Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine.

Authors:  Tamara B Garcia; Susan P Fosmire; Christopher C Porter
Journal:  Leuk Res       Date:  2017-11-11       Impact factor: 3.156

3.  Mechanism of the promotion of steatotic HepG2 cell apoptosis by cholesterol.

Authors:  Chunyan Zhu; Ping Xie; Fei Zhao; Lingqiang Zhang; Wei An; Yutao Zhan
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.

Authors:  Noriaki Tanaka; Ameeta A Patel; Jiping Wang; Mitchell J Frederick; Nene N Kalu; Mei Zhao; Alison L Fitzgerald; Tong-xin Xie; Natalie L Silver; Carlos Caulin; Ge Zhou; Heath D Skinner; Faye M Johnson; Jeffrey N Myers; Abdullah A Osman
Journal:  Clin Cancer Res       Date:  2015-06-29       Impact factor: 12.531

5.  Apoptosis resistance, mitotic catastrophe, and loss of ploidy control in Burkitt lymphoma.

Authors:  Cindrilla Chumduri; Bernhard Gillissen; Anja Richter; Antje Richter; Ana Milojkovic; Tim Overkamp; Anja Müller; Christiane Pott; Peter T Daniel
Journal:  J Mol Med (Berl)       Date:  2014-12-30       Impact factor: 4.599

6.  ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.

Authors:  Patrick Y Lang; Gouri J Nanjangud; Marina Sokolsky-Papkov; Christine Shaw; Duhyeong Hwang; Joel S Parker; Alexander V Kabanov; Timothy R Gershon
Journal:  Development       Date:  2016-11-01       Impact factor: 6.868

7.  Cyclin-dependent kinase-1 (Cdk1)/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins.

Authors:  Nandini Sakurikar; Joshua M Eichhorn; Timothy C Chambers
Journal:  J Biol Chem       Date:  2012-09-10       Impact factor: 5.157

8.  SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models.

Authors:  Jeremy A Hengst; Taryn E Dick; Arati Sharma; Kenichiro Doi; Shailaja Hegde; Su-Fern Tan; Laura M Geffert; Todd E Fox; Arun K Sharma; Dhimant Desai; Shantu Amin; Mark Kester; Thomas P Loughran; Robert F Paulson; David F Claxton; Hong-Gang Wang; Jong K Yun
Journal:  Cancer Transl Med       Date:  2017-08-14

9.  Phosphoproteomics and Proteomics Reveal Metabolism as a Key Node in LPS-Induced Acute Inflammation in RAW264.7.

Authors:  Yu Luo; Qing Jiang; Zhengwen Zhu; Haseeb Sattar; Jiasi Wu; Wenge Huang; Siyu Su; Yusheng Liang; Ping Wang; Xianli Meng
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 10.  Decoding and unlocking the BCL-2 dependency of cancer cells.

Authors:  Philippe Juin; Olivier Geneste; Fabien Gautier; Stéphane Depil; Mario Campone
Journal:  Nat Rev Cancer       Date:  2013-06-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.